Feb 13, 2017 21:16 pm UTC| Business
Merger creates a clinical-stage biopharmaceutical company focused on the discovery and development of select microRNA-targeted therapies Combined company, renamed Miragen Therapeutics, Inc., to commence trading on Nasdaq...
Microchip Technology to Host Conference Call to Discuss Its Recent Debt Transactions
Feb 13, 2017 21:15 pm UTC| Business
CHANDLER, Ariz., Feb. 13, 2017 -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, announced today that the Company will host a short...
FreightCar America, Inc. Announces Date for Fourth Quarter 2016 Earnings Conference Call
Feb 13, 2017 21:15 pm UTC| Business
CHICAGO, Feb. 13, 2017 -- FreightCar America, Inc. (Nasdaq:RAIL) will host a conference call and live webcast on Tuesday February 28, 2017 at 11:00 a.m. (Eastern Standard Time) to discuss the Company’s fourth quarter...
Triangle Capital Corporation Invests in Lakeview Health
Feb 13, 2017 21:15 pm UTC| Business
RALEIGH, N.C., Feb. 13, 2017 -- Triangle Capital Corporation (NYSE:TCAP) (“Triangle” or the “Company”), a leading provider of capital to lower middle market companies, announced today that it closed an investment in...
La-Z-Boy Announces Fiscal 2017 Third-Quarter Conference Call
Feb 13, 2017 21:15 pm UTC| Business
MONROE, Mich., Feb. 13, 2017 -- La-Z-Boy Incorporated (NYSE:LZB) will report its fiscal 2017 third-quarter operating results after the close of trading on the New York Stock Exchange on Tuesday, February 21, 2017, and...
Feb 13, 2017 21:15 pm UTC| Business
HOUSTON, TEXAS, Feb. 13, 2017 -- Quanex Building Products Corporation (NYSE: NX) (“Quanex” or the “Company”) today announced plans to release its fiscal first quarter 2017 results on Monday, March 6, 2017 after trading...
Feb 13, 2017 21:15 pm UTC| Business
NEW YORK, Feb. 13, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment...